ChemoFx® provides an edge
We believe every cancer patient deserves the best treatment possible. And we've dedicated our lives to making it happen. That's why we've developed ChemoFx—to give you a clear and powerful advantage and improve your chances of successful treatment.

What is ChemoFx
ChemoFx is a Drug Response Marker.  It determines how an individual gynecologic cancer patient is likely to respond to various types of chemotherapy by testing the treatment options on that patient's cancer cells before choosing one for the patient. While not intended to replace standard of care therapy, ChemoFx provides valuable insights that help guide physicians' treatment decisions, giving you an edge against gynecologic cancer.

Now your cancer can undergo chemotherapy before you do
Developed to improve your chances of successful treatment, ChemoFx is a laboratory test that determines how your particular cancer cells may respond to different chemotherapies. You can take comfort in the fact that testing your cancer cells in the lab—before they're treated in your body—may help guide your doctor in selecting the chemotherapy that is most likely to be effective for you.

When ChemoFx is used
ChemoFx can be used over a broad range of chemotherapies for all gynecologic cancers, including ovarian, endometrial, cervical, and gynecologic sarcomas.* With its broad range, ChemoFx is designed to meet the needs of many patients. It may be used during several stages of your care, including:
  • During your initial surgery
  • If you are not able to tolerate the typical treatment most often recommended for your
    cancer type
  • If you don’t respond (refractory) to initial treatment
  • If you have a rare cancer and there are no established treatment guidelines
  • If your cancer has recurred
*Non-gynecologic tumors, including leukemia and lymphomas are not tested at present.

Why ChemoFx?
Your physician is using every advantage available to improve the odds in your fight against cancer. ChemoFx is designed to reduce your risk of receiving therapies that are ineffective or to identify alternatives when the typical treatments recommended for your type of cancer cannot be tolerated. The best part is, most patients don't have to undergo any additional procedures for this test.

How it works
A portion of your cancer cells or fluid is removed during your surgery or biopsy and sent to our lab. Your cancer cells are grown in our lab and treated with a number of chemotherapies. A report is sent to your physician that details how your cancer cells responded to each type of chemotherapy. Your doctor can use the report to help determine your treatment regimen. With ChemoFx, you and your physician will have the advantage of knowing which chemotherapies are more likely to be effective before you're ever treated with them.

Although unlikely, in 8–10% of cases, testing cannot be completed.

Jane's cancer is being treated with multiple chemotherapies. Jane is being treated to lunch with the girls.
Patient education

Chemotherapy reimbursement link

Give a friend an edge